FindTrial
Sign In

Evaluate the efficacy of Navakarshika Kwatha on Vatarakta (Gout) Patients of Different Dehaprakriti

Effect Of Navakarshika Kwatha on Vatarakta (Gout) Patients of Different Dehaprakriti - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/04/108507
Enrollment
30
Registered
2026-04-16
Start date
Unknown
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M109- Gout, unspecified

Interventions

None listed

Sponsors

Dr Aurosikha Bhoi
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients from age group 15-50 years Patients of both genders( male and female) Patients having serum uric acid level more than 7mg/dl Associated symptoms of Vatarakta(Gout)as per protocol designed

Exclusion criteria

Exclusion criteria: Patients below age group of 15 and above age group of 50years Any other inflammatory joint disorder like RA,tubercular arthritis etc. Patient suffering from any other systematic disorder Patient on Chronic use o NSAID

Design outcomes

Primary

MeasureTime frame
Reduction in Itching Reduction in Burning Sensation Reduction in Pain and Tenderness Reduction in Stiffness Reduction in Edema Reduction in Serum Acid LevelTimepoint: 30days—

Secondary

MeasureTime frame
Increased in Sleep Quality. Increase in Appetite. Increase in Bowel Habit.Timepoint: 30 days—

Countries

India

Contacts

Public ContactDr Aurosikha Bhoi

Goverment Ayurvedic College and Hospital,Balangir

utkalini2006@gmail.com8658483032

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: May 1, 2026